HannaKim(Kim)GagginMD
Cardiology • Boston, MACardiologist, Massachusetts General Hospital Associate Professor, Harvard Medical School Director, Amyloidosis Program
Dr. Gaggin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Yawkey 5, MGH
Boston, MA 02114Phone+1 617-726-2709Fax+1 617-643-6844
Summary
- Dr. Hanna (Kim) Gaggin is a Cardiologist based in Boston, MA. She completed her Residency in Internal Medicine at the University of Virginia Medical Center and then went on to do a fellowship in Cardiovascular Disease at UPMC Medical Education.
Education & Training
UPMC Medical EducationFellowship, Cardiovascular Disease, 2007 - 2010
University of Virginia Medical CenterResidency, Internal Medicine, 2003 - 2006
Eastern Virginia Medical SchoolClass of 2003
Certifications & Licensure
MA State Medical License 2006 - 2025
PA State Medical License 2007 - 2010
VA State Medical License 2003 - 2006
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure Start of enrollment: 2016 Apr 07
Publications & Presentations
PubMed
- 10 citationsATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.Thomas H. Brannagan, Michaela Auer-Grumbach, John L. Berk, Chiara Briani, Vera Bril
Orphanet Journal of Rare Diseases. 2021-05-06 - 116 citationsCardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.Reza Mohebi, Chen Chen, Nasrien E Ibrahim, Cian P McCarthy, Hanna K Gaggin
Journal of the American College of Cardiology. 2022-08-09 - 119 citationsInterpreting Cardiac Troponin Results from High-Sensitivity Assays in Chronic Kidney Disease without Acute Coronary SyndromeChristopher DeFilippi, Stephen L. Seliger, Walter E. Kelley, Show-Hong Duh, Michael K. Hise
Clinical Chemistry. 2012-09-01
Journal Articles
- A Clinical and Proteomics Approach to Predict the Presence of Obstructive Peripheral Arterial Disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseas...Shweta R Motiwala, Cian P McCarthy, Nasrien E Ibrahim, Hanna K Gaggin, Joseph M Garasic, Clinical Cardiology
- Predicting New‐Onset HF in Patients Undergoing Coronary or Peripheral Angiography: Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLAN...Nasrien E Ibrahim, Hanna K Gaggin, Shweta R Motiwala, ESC Heart Failure
Press Mentions
Blood Pressure Drugs Tied to Surprising Fracture RiskMay 22nd, 2024
NCDR Research to Be Highlighted at ACC.19March 11th, 2019
Heart Health Month 2019: Spotlighting Mass General’s Heart Researchers (Part 2)February 12th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
